2019
Duration of the psychosis prodrome
Powers AR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Duration of the psychosis prodrome. Schizophrenia Research 2019, 216: 443-449. PMID: 31806523, PMCID: PMC7539292, DOI: 10.1016/j.schres.2019.10.051.Peer-Reviewed Original ResearchConceptsSyndrome onsetPsychosis prodromeNorth American Prodrome Longitudinal StudyCHR-P patientsClinical high-risk syndromeHigh-risk syndromePsychosis risk syndromeMedication exposureProdromal periodFrank psychosisRisk syndromeProdromePsychosisLongitudinal studySyndromeOnsetStructured interviewsDurationFirst descriptionThirdYearsFinal thirdPatientsMonths
2009
Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study
Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study. Schizophrenia Bulletin 2009, 35: 894-908. PMID: 19386578, PMCID: PMC2728816, DOI: 10.1093/schbul/sbp027.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentComorbidityDisability EvaluationDisease ProgressionEarly DiagnosisFemaleHumansLongitudinal StudiesMalePatient Acceptance of Health CarePsychiatric Status Rating ScalesPsychometricsPsychotic DisordersReproducibility of ResultsRisk AssessmentSchizophreniaSchizophrenic PsychologySchizotypal Personality DisorderSocial AdjustmentUnited StatesYoung AdultConceptsProdromal risk syndromeNorth American Prodrome Longitudinal StudyRisk syndromeFirst psychosisProdromal SyndromesSchizotypal personality disorder groupDiagnostic validityLongitudinal studyFHR subjectsYounger patientsPersonality disorder groupSPD patientsPrevention StudyProdromal patientsPsychosis prodromeSyndrome patientsNC subjectsPatientsMeeting criteriaFuture psychosisSyndromeMental disordersPsychosisDisorder groupStatistical Manual
2007
Aripiprazole in the treatment of the psychosis prodrome
Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, Mathalon DH, Miller TJ, McGlashan TH. Aripiprazole in the treatment of the psychosis prodrome. The British Journal Of Psychiatry. Supplement 2007, 191: s96-s101. PMID: 18055946, DOI: 10.1192/bjp.191.51.s96.Peer-Reviewed Original ResearchConceptsPsychosis prodromeMixed-effects repeated-measures analysisShort-term efficacySymptom total scoreSingle-site trialRepeated-measures analysisAripiprazole treatmentAdverse eventsFinal visitSafety profilePromising efficacyProdromal phasePsychotic disordersScale scoreBaseline levelsWeight gainFirst weekProdromeTotal scoreAripiprazoleTreatmentNeuropsychological measuresPreliminary evidenceWeeksEfficacy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply